Regeneron reported Q4 2024 earnings today and declared its first-ever dividend of $0.88 per quarter. Click here to know what ...

Q4 2024 Earnings Call Transcript February 4, 2025 Operator: Hello, and welcome to Regeneron Pharmaceuticals Fourth Quarter ...

SNY earnings call for the period ending December 31, 2024.

Secret Lives of Mormon Wives star Mikayla Matthews shared a post on Instagram, in which she gave an update on her journey ...

Immunology superstar Dupixent, which first brought Regeneron and Sanofi together in 2007, has entered its megablockbuster era ...

Analyst Chris Schott from J.P. Morgan maintained a Buy rating on Regeneron (REGN – Research Report) and keeping the price target at ...

Bristol Myers Squibb has continued its ruthless cost-cutting push, dropping plans to commercialize a rival to Dupixent despite meeting its phase 3 goals and pumping the brakes on a would-be ...

Meanwhile, Sanofi's asthma treatment, Dupixent, generated 3.46 billion euros ... and make sure their analysis is clear and in no way misleading or deceptive. To further protect the integrity ...

Pharma launches up 56.5%, reaching sales of €0.8 billion, 8% of total sales, led by ALTUVIIIO Dupixent sales up ... their analysis is clear and in no way misleading or deceptive.